🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is researching an experimental drug called REGN3767, also known ...
Status
Active Not Recruiting
Location
UC San Diego
Start Date
2023-01-16
Trial ID
NCT05608291
Treatments Being Tested
This multi-site, Phase 1/2 clinical trial is an open-label study to identif...
Status
Recruiting
Location
Precision NextGen Oncology
Start Date
2023-11-01
Trial ID
NCT06047379
Phase II, 2-cohort, single arm trial treated with the combination of the fo...
Status
Active Not Recruiting
Location
University of Chicago Comprehensive Cancer Center
Start Date
2018-03-26
Trial ID
NCT03360890
Treatments Being Tested
This study will test whether vaccination with viagenpumatucel-L combined wi...
Status
Completed
Location
University of Arizona Cancer Center
Start Date
2015-04-15
Trial ID
NCT02439450
Treatments Being Tested
This study is to assess the safety and antitumor activity of ABL103 plus pe...
Status
Recruiting
Location
UH Cleveland Medical Center
Start Date
2025-08-06
Trial ID
NCT07158918
Treatments Being Tested
The study is a 2-part study of Tinodasertib alone or in combination with Pe...
Status
Recruiting
Location
Chris O'Brien Lifehouse
Start Date
2023-04-14
Trial ID
NCT05462236
Treatments Being Tested
This first time in human (FTIH) open-label, dose escalation study will asse...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-08-30
Trial ID
NCT02783300
Treatments Being Tested
The main goals are after treatment given before surgery, to measure the num...
Status
Recruiting
Location
Southern Cancer Center (SCC) ( Site 8004)
Start Date
2025-03-20
Trial ID
NCT06788912
This is a multicenter screening protocol designed to identify patients with...
Status
Terminated
Location
Southern Cancer Center
Start Date
2021-01-19
Trial ID
NCT04698681
The study is designed to assess the therapeutic efficacy and toxicity of th...
Status
Unknown
Location
National Cancer Institute
Start Date
2018-06
Trial ID
NCT03539328
Treatments Being Tested